Showing results (281-290 of 447) with videos related to
Sort By:
Pageof 45
Clinical Lung Cancer|February 14, 2021
Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint InhibitorsSally C M Lau, Aline Fusco Fares, Lisa W Le, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 29, 2026
Endobronchial Ultrasound-Guided Biopsy Derived Lung Cancer Models: A Platform for Precision TherapyTakamasa Koga, Hiroyuki Ogawa, Nikolina Radulovich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2017
Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant ChemotherapyFrances A Shepherd, Benjamin Lacas, Gwénaël Le Teuff, et al.Cancer Research|May 31, 2002
Molecular profiling of non-small cell lung cancer and correlation with disease-free survivalDennis A Wigle, Igor Jurisica, Niki Radulovich, et al.Therapeutic Advances in Medical Oncology|October 30, 2025
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastasesMaisam Makarem, Tuan Hoang, Mitchell J Elliott, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 23, 2016
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled AnalysisXiaoli Ma, Gwénaël Le Teuff, Benjamin Lacas, et al.Current Oncology (Toronto, Ont.)|January 20, 2021
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in AdultsD Gwyn Bebb, Shantanu Banerji, Normand Blais, et al.Nature Methods|March 25, 2014
The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cellsJulia Petschnigg, Bella Groisman, Max Kotlyar, et al.Cancer Cell|March 16, 2005
DJ-1, a novel regulator of the tumor suppressor PTENRaymond H Kim, Malte Peters, YingJu Jang, et al.Lung Cancer (Amsterdam, Netherlands)|July 5, 2024
Clinical and pathological predictors of engraftment for patient-derived xenografts in lung adenocarcinomaHiroyuki Ogawa, Takamasa Koga, Nhu-An Pham, et al.Pageof 45